eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Boehringer Ingelheim Pharmaceuticals, Inc - Comment

Boehringer Ingelheim Pharmaceuticals, Inc - Comment

Document ID: FDA-2013-D-0068-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 15 2013, at 12:00 AM Eastern Daylight Time
Date Posted: May 20 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 4 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 21 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-847r-hnah
View Document:  View as format xml

View Comment

See Attached

Attachments:

Boehringer Ingelheim Pharmaceuticals Comment 2013-D-0068 ICH S10 Photosafety Letter

Title:
Boehringer Ingelheim Pharmaceuticals Comment 2013-D-0068 ICH S10 Photosafety Letter

View Attachment: View as format pdf

Related Comments

   
Total: 5
International Council for Animal Protection in Pharmaceutical Programmes (ICAPPP) - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0007

Mar 21,2013 11:59 PM ET
Merck & Co, Inc. - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0003

Mar 21,2013 11:59 PM ET
Boehringer Ingelheim Pharmaceuticals, Inc - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0004

Mar 21,2013 11:59 PM ET
Sanofi - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0006

Mar 21,2013 11:59 PM ET
Roche Genentech - Comment
Public Submission    Posted: 05/20/2013     ID: FDA-2013-D-0068-0008

Mar 21,2013 11:59 PM ET